Clinical trial
Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill
NCT01823484 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill
- Lead sponsor
- Zhongda Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2012
- Completion date
- Not reported
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, critically ill, septic shock